Last updated: April 15, 2020
Sponsor: University Hospital, Geneva
Overall Status: Active - Recruiting
Phase
N/A
Condition
Holoprosencephaly
Birth Defects
Treatment
N/AClinical Study ID
NCT03044769
CLA-2016
Ages < 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients diagnosed with congenital lung anomalies
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 100
Study Start date:
April 01, 2016
Estimated Completion Date:
April 01, 2026
Study Description
Connect with a study center
Geneva University Hospital
Geneva, 1205
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.